Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 417

MDMetrix jots down $3m

Seattle Children’s EHR management software publisher MDMetrix has now raised $4m in all following a seed round backed by the investment arm of Washington Research Foundation.

May 16, 2019

Locate Bio locks down $2.6m

The additional cash will allow University of Nottingham biomedicine spinout Locate Bio to advance two internal programs and support its collaborations with external partners.

May 16, 2019

Clevertar clutches onto $275,000

The board at Flinders University-founded medical avatar software platform Clevertar has agreed to pump in funding to clear the spinout's outstanding liabilities to creditors including the university.

May 16, 2019

Icometrix processes $18m

Icometrix developers brain imaging technology based on KU Leuven and University of Antwerp research to help assess conditions such as Alzheimer’s disease.

May 16, 2019

Phathom scares up $90m

Phathom Pharmaceuticals has been launched with $140m in debt and equity financing to commercialise a gastrointestinal disease drug licensed from Takeda.

May 16, 2019

Kevrekian seizes CVS Health promotion

Gregor Kevrekian, previously senior director of CVS Health’s corporate development and venture investing business, has ascended to executive director.

May 16, 2019

NextStep Robotics drills $600,000

NextStep Robotics, which last raised funding in February 2018, is commercialising research from two University of Maryland campuses and the Baltimore Veterans Affairs Motor Performance Laboratory.

May 15, 2019

Healthineers prompts Siemens' Pompl to new role

René Pompl, formerly principal at Siemens’ Next47, has joined the corporate’s medical-focused Healthineers division as manager of venture technology.

May 15, 2019

TreeFrog leaps into $7.8m series A

Satt Aquitaine-founded TreeFrog has now raised $11.1m in equity and grant funding, having secured follow-on contributions from investors including the tech transfer office.

May 14, 2019

Axcella accepts public listing

Metabolic therapy developer Axcella Health has priced its shares at $20 each in an offering that enabled Nestlé Health Science to exit.

May 14, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here